Markets

Telomir Pharmaceuticals Announces ~$5.6M Investment In PIPE Financing Through Common Stock Issuance

Oct 6, 2026 · 08:10 AM ET· updated 14h ago

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer, today announced an approximately $5.6

Why It Matters

Telomir raised about $5.6 million by selling new shares to investors. This gives the company cash to keep developing its cancer medicines.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

TELO1.18

-0.03 (-2.48%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.